Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Novel Methods for Delivering Cell Specific Nucleic Acid Therapeutics
| Reference number | 2007-00077 |
| Coordinator | GE Healthcare Bio-Sciences AB - GE Healthcare Bio-Sciences AB, Huvudkontor |
| Funding from Vinnova | SEK 3 682 500 |
| Project duration | May 2007 - April 2010 |
| Status | Completed |
